Cellcept and Gentamicin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Gentamicin (gentamicin sulfate). Common drug interactions include sinusitis among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Gentamicin. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.



On Jul, 26, 2026

81 people who take Cellcept and Gentamicin together, and have interactions are studied.

Cellcept and Gentamicin drug interactions.

What are the common drug interactions of Cellcept and Gentamicin, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Limb injury
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Pulmonary haemorrhage (acute bleeding from the lung)
  5. Urinary tract infection bacterial
  6. Peripheral swelling
  7. Ear infection
  8. Eye infection
  9. Fall
  10. Fatigue (feeling of tiredness)

male:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Anaphylactic reaction (serious allergic reaction)
  5. Angioedema (rapid swelling of the dermis)
  6. Blood pressure fluctuation
  7. Burning sensation
  8. Dizziness
  9. Drug hypersensitivity
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Cellcept and Gentamicin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Aspergillosis (an infection caused by a fungus called aspergillus)
  2. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
  3. Multi-organ failure (multisystem organ failure)
  4. Platelet count decreased
  5. Renal failure (kidney dysfunction)
  6. White blood cell count decreased
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Stenotrophomonas sepsis (blood infection by stenotrophomonas)
  9. White blood cell count increased
  10. Anaphylactic reaction (serious allergic reaction)

10-19:

  1. Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
  2. Blood bilirubin increased
  3. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  4. Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)
  5. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  6. Hospitalisation
  7. Hypertension (high blood pressure)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Sweating increased (excess sweating)

20-29:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Bone marrow failure
  3. Dyspnoea (difficult or laboured respiration)
  4. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  5. Kidney transplant rejection
  6. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  7. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  8. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  9. Pyrexia (fever)
  10. Scotoma (an area of diminished vision within the visual field)

30-39:

  1. Depression
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Pyrexia (fever)
  7. Bone disorder
  8. Aortic valve disease
  9. Blood pressure increased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

40-49:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Hypotension (abnormally low blood pressure)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Activated partial thromboplastin time prolonged
  5. Cardiac failure
  6. Cardiomegaly (increased size of heart than normal)
  7. Cerebral infarction (less blood supply to brain resulting tissue damage)
  8. Chest pain
  9. Muscle weakness (a lack of muscle strength)
  10. Pneumonia

50-59:

  1. Substance-induced psychotic disorder
  2. Wound infection
  3. Renal failure (kidney dysfunction)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Arthralgia (joint pain)
  7. Blood glucose increased
  8. Hypertension (high blood pressure)
  9. Inflammation
  10. Joint swelling

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Oesophageal disorder (disease of oesophagus)
  3. Chest pain
  4. Diarrhoea
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Glottis carcinoma (cancer of glottis)
  8. Headache (pain in head)
  9. Malignant neoplasm progression (cancer tumour came back)
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Pain: 8 people, 9.88%
  2. High Blood Pressure: 7 people, 8.64%
  3. Immunodeficiency Common Variable: 6 people, 7.41%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 7.41%
  5. Asthma: 5 people, 6.17%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Gentamicin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gentamicin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and gentamicin sulfate (the active ingredients of Cellcept and Gentamicin, respectively), and Cellcept and Gentamicin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: